C. Ola Landgren, Leader of Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared a post by Sylvester Comprehensive Cancer Center on LinkedIn:
”We’re thrilled to have Rafat Abonour, M.D. on the team here at Sylvester Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami. Dr Abonour will serve as our multiple myeloma program leader at the new SoLé Mia facility in North Miami.”
Quoting Sylvester Comprehensive Cancer Center‘s post:
”We’re proud to announce the appointment of Rafat Abonour, M.D., as program leader for multiple myeloma at our new SoLé Mia facility in North Miami. A luminary in hematologic oncology, Dr. Abonour brings decades of clinical and research expertise to this pivotal role, marking a transformative moment for cancer care in South Florida.
‘Dr. Rafat Abonour is a highly respected myeloma expert, and we are thrilled to welcome him to Sylvester’s Myeloma Institute at SoLé Mia, our new site located on the north side of Miami,’ said C. Ola Landgren, director, Sylvester Myeloma Institute.
At SoLé Mia, Dr. Abonour will lead the development of a comprehensive myeloma program that bridges front-line research with personalized clinical care.
More posts featuring C. Ola Landgren on OncoDaily.